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Abstract 
 
 
Tyrosine kinase Src substrates, Tks4 and Tks5, are involved in the formation of 
podosomes and invadopodia during cell migration and cancer cell metastasis. Most recently, the 
α isoform of Tks5 has been discovered highly expressed in cancer cells, suggesting that the Tks5 
α isoform plays essential roles in the regulation of invadopodia. In the Tks protein family, only 
the Tks5 α isoform contains a PX domain, which binds an important second messenger, PI (3,4) 
P2. Using a monoclonal antibody as an antigen-specific-probe to detect the protein of interest 
could be a useful tool that would provide a highly specific recognition at the molecular level. 
This project aims to develop a highly specific rabbit monoclonal antibody (mAb) to target the 
human Tks5 α isoform (specifically the PX domain) in cancer cells. In this study we describe the 
first step of the entire process, immunogen preparation. The results showed that the recombinant 
protein, hTks5 α PX domain, was successfully expressed in BL21 E.coli competent cells and the 
purified antibody has high immunoreactivity. Other promising results obtained from western blot 
and immunofluorescence analyses indicated the developing antibody samples have high targeting 
effects on human Tks5 α isoform PX domain.  
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Introduction 
 
 
The impact of cancer worldwide is devastating. For example, cancer is the number two 
cause of death in the United States in 2013 (Xu et al., 2016). Many studies have investigated how 
cancer cells invade the body to produce tumor growth and metastasis. Specifically, important 
research is being done on the role of podosomes and invadopodia in cell migration and 
metastasis. Both podosomes and invadopodia behave invasively. Both structures are actin rich 
protrusions of ventral plasma membrane structures that associate with cell attachment and 
degrade the extracellular matrix, ECM (Gimona et al., 2008; Murphy & Courtneidge, 2011). 
Podosomes are found in normal cells while invadopodia arise in cancer cells (Gimona et al., 
2008; Murphy & Courtneidge, 2011) (see Figure 1). There is much debate in the field regarding 
the distinction between these two membrane structures — the overall architecture and function 
display some similarities but the morphological and molecular structures are dissimilar (Murphy 
& Courtneidge, 2011).  For instance, both structures are transient membrane structures that are 
regulated by several key proteins including the scaffolding proteins (Tks4 and Tks5), the 
metalloprotease (MT1-MMP), and actin regulators cortactin and (N-WASP) (Murphy & 
Courtneidge, 2011). However, the half-life of actin turn-over in these two structures are very 
different. Invadopodia are more stable in comparison to podosomes (Murphy & Courtneidge, 
2011). Invadopodia can protrude further to the ECM while podosomes only have minimal 
protrusion (Murphy & Courtneidge, 2011). In order to characterize the detailed roles of 
invadopodia in tumor progression and metastasis, it is important to see their localization in vivo 
(Courtneidge, 2012). In recent years, two crucial tyrosine kinase Src substrates, Tks4 and Tks5, 
were identified and discovered to be very important in cancer cell invasion and tumor growth. 
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Both Tks4 and Tks5 are vital for the formation of podosomes and invadopodia (Blouw et al., 
2015; Courtneidge, 2012). Research has shown that Tks4 and Tks5 also involved in embryonic 
development (Courtneidge, 2012). 
 In humans, Tks4 and Tks5 are encoded by SH3PXD2B and SH3PXD2A genes 
respectively, and their sequence identity is 47%. (Cejudo-Martin et al., 2014; Courtneidge, 
2005). Both Tks4 and Tks5 contain Src phosphorylation sites, proline-rich motifs, Src homology 
3 (SH3) domains and a phox homology (PX) domain — the PX domain in Tks4 is followed by 
four SH3 domains while the PX domain in Tks5 is located at the N-terminus and followed by 
five SH3 domains (Cejudo-Martin et al., 2014; Courtneidge et al., 2005; Courtneidge 2012; 
Stylli et al., 2009) (see Figure 2). No catalytic domain was found in both Tks 4 and Tks5, so they 
were designated as adaptor or scaffolding proteins that interact with and bind to other proteins 
and lipids (Courtneidge et al., 2005). Tks4 and Tks5 have specific scaffolding functions in the 
formation of protrusion of membrane structures (Courtneidge et al, 2005; Courtneidge, 2012). 
Tks5 was recently found highly expressed in human cancer cells culture (in vitro) and tumor 
tissue (in vivo), suggesting Tks5 plays a critical role in regulating tumor progression and 
metastasis (Courtneidge, 2012). Although Tks5 does not have any catalytic activity, it most 
likely associates with other key regulators for the formation of invadopodia (Buschman et al., 
2009; Courtneidge et al., 2005). Phosphatidylinositol 3,4 bisphosphate (PI (3,4) P2) is a 
phosphorylated inositol lipid, a second messenger activates many essential cell signaling 
pathways, which binds to the PX domain of Tks5 initiates the formation of invadopodia (Abram 
et al., 2003; Buschman et al., 2009; Courtneidge, 2012; Oikawa et al, 2008). The transmembrane 
metalloproteases ADAMs binds to the fifth SH3 domain of Tks5 (Abram et al., 2003; Buschman 
et al., 2009). The ADAMs play important roles in regulating cell migration, cell adhesion, 
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proteolysis and signaling (Edwards et al., 2008). Tks5 tyrosine residues are phosphorylated by 
Src in Src transformed cells (Courtneidge et al., 2005). In prostate cancer cell lines, invasive 
behavior increased as the activities of Src tyrosine kinase and phosphorylation of Tks5 increased 
(Burger et al., 2014). Tks5 is structurally related to p47phox protein, one of the foremost cytosolic 
regulator subunits of the phagocytic NADPH oxidase, which contains one PX domain and two 
SH3 domains (Buschman et al., 2009; Diaz et al., 2009; Wang et al., 2015). Tks4 and Tks5 
interact with p47phox- related organizer to localize Nox1 in invadopodia (Gianni et al., 2011). In 
the absence of Tks4, Tks5 and other invadopodia proteins accumulated at the membrane, actin 
polymerization and ECM degradation would not occur suggesting Tks4 play a role to localize a 
transmembrane metalloprotease, MT1-MMP, in invadopodia (Courtneidge, 2012).  
The current focus is on investigating the cellular and molecular mechanism of Tks5 in the 
formation of invadopodia. The most recent study on investigating the genetic disruption of 
mouse sh3pxd2a gene identified multiple isoforms of Tks5 (see Figure 3) and discovered the PX 
domain only appears in the α isoform (long isoform) of Tks5 (Cejudo-Martin et al., 2014). 
Different alternative transcriptions of the sh3pxd2a gene produce various isoforms of Tks5 
(Cejudo-Martin et al., 2014). Another study found that the balance expression between Tks5 α 
isoform and Tks5 short isoform seems to be more critical for metastasis invasion than the total 
level of Tks5 alone (Li et al., 2013). Tks5 α isoform was found highly expressed in metastatic 
primary tumor- and metastasis- derived cells while Tks 5 short isoform was found mainly 
expressed in nonmetastatic primary tumor-derived cells, furthermore, increased expression of 
Tks 5 short isoform inhibited gelatin proteolysis and thus decreased the stability of invadopodia 
(Li et al., 2013). 
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In the light of the above findings, our goal was to observe the locations of Tks5 α isoform 
in human cancer cell samples. Tks5 polyclonal antibody (anti-Tks5 1731) was previously 
generated in the Courtneidge lab but we do not yet have a highly specific monoclonal antibody to 
target the PX domain of Tks5 α isoform. In this project, the recombinant protein (GST-tagged 
human Tks5 α PX domain) acts as immunogen for the development of rabbit monoclonal 
antibody.  First, the human Tks5 α PX domain DNA fragment was obtained by polymerase chain 
reaction (PCR), and cloned into pGEX 4T1 using restriction sites. BL21 E.coli cells was used for 
transformation because this genetic modified lab strain is suitable for transformation and protein 
expression with high efficiency.  The purified protein was sent to Abcam (a company that offers 
antibody development services), to generate a rabbit monoclonal antibody (mAb) to Tks5 α 
isoform PX domain. Rabbits can produce high titers of antibodies with high affinity to human 
epitopes despite the antigens not being able to evoke immune response in mice (Rossi et al., 
2005).  The process of generating a highly specific mAb takes several months. To produce 
antibodies, rabbits are injected with an immunogen. Though the rabbits used for generating 
antibodies are genetically identical, due to the complexity of biological systems they could still 
respond to the same immunogen differently (Antibody Purification Methods, 2016). At various 
stages of development, samples of antibodies are sent back to the Courtneidge lab for testing 
their specificity in targeting the Tks5 α isoform PX domain. These were tested with western 
blotting and immunofluorescence assays and have thus far been successful. The final goal of this 
project will be to develop a highly specific rabbit mAb, which acts as an antigen-specific-probe, 
to target the PX domain of the α isoform of hTks5. In this manner, the locations of hTks5 α 
isoform can be detected and visualized using immunohistochemistry in samples obtained from 
cancer patients, and thus helps draw conclusions about how cancers progress and metastasize. 
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For the development of rabbit mAb, immunogen preparation is the first step of the entire 
process and followed by immunization, hybridoma creation, fusion and screening, subcloning 
and finally, hybridoma delivery (Abcam, 2016). Immunogenicity is greatly influenced by the 
chemical composition of the immunogen — optimal immunogen should have B cell and T cell 
epitopes, and binding sites for MHC (major histocompatibility complex) class II molecules —
and the level of immune response of the injected animals (Dübel, 2014). In order to produce 
monoclonal antisera, a purified immunogen should be homogeneous. Thus, immunogen 
preparation is a crucial step for the development of mAb (Antibody Purification Methods, 2016).   
In the present study, we describe this first step of the entire process including purification and 
extraction as well as quality and quantity control for the recombinant protein, hTks5 α PX 
domain. Because P47phox is structurally related to Tks5 α we therefore also constructed and 
purified GST protein and p47phox PX domain (recombinant protein) for the use of counter-
screening agents in the ELISA test by Abcam. The idea was not to pick clones that either reacted 
with GST or P47phox PX domain. 
 
Figure 1. Images of Co-
immunostaining cells. 
Podosomes are found 
in normal cell types 
(top). Invadopodia form 
in various cancer cell 
types (bottom). White 
arrows point out the 
locations of 
invadopodia and 
podosomes, F-actin 
were stained in red and 
cortactin were stained 
in green, nuclei were 
stained in blue (Murphy 
& Courtneidge, 2011). 
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Figure 2. Schematic diagram of the 
architectures of Tks4 and Tks5. Both 
proteins contain a PX domain, the 
SH3 domains, Src phosphorylation 
sites (pY and YEEI) and proline-rich 
motifs (PxxP) (Courtneidge, 2012). 
 
 
 
 
 
 
 
Figure 3. Schematic diagram of the 
architectures of Tks5 α/Tks5 long, Tks5 
β and Tks5 short isoforms. Different 
isoforms of Tks 5 are encoded by the 
mouse sh3pxd2a gene. Only the Tks5 
α/ Tks5 long isoform contains a PX 
domain (blue). The SH3 domains 
appear on all three isoforms (Cejudo-
Martin et al., 2014). 
 
 
 
 
Materials and Methods 
 
The GST vector (pGEX 4T1) was previously purchased and p47phox PX domain in pGEX 
4T1 was designed and constructed by a former lab member. The protein extraction, purification 
and analysis steps describe in here are identical for GST, p47phox PX domain and hTks5 α PX 
domain.   
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Polymerase Chain Reaction and Cloning (hTks5 α PX domain) 
A PCR fragment was generated using specific Tks5 α PX domain primers that contained 
specific RE sites for cloning (BamHI and EcoRI). DNA template used was from a previous 
vector containing the PX sequence (Tks5-GFP). Once generated, the fragment was ligated into a 
pGEX 4T1 vector containing a GST tag. 
 
Transformation (hTks 5 α PX domain) 
10 ng of the recombinant plasmid (insert: hTks5-PX; GST fusion vector: pGEX-4T1) was 
transformed into BL21 competent E.coli cells. After placing the cell mixture on ice for 30 
minutes, the mixture was subjected to heat shock at 42 oC for10 seconds and then the mixture 
was placed back on ice for 5 minutes. 950 µl of SOC medium (super Optimal broth (SOB) with 
Catabolite repression) was added into the cell mixture to maximize the transformation efficiency 
followed by incubation at 37 oC for 1 hour and shaking at 250 rpm. 25 µl and 50 µl of 
transformed cells were spread separately onto two LB ampicillin plates to obtain single colonies, 
and incubated overnight at 37 oC. 
 
Expression & Purification of Proteins (hTks5 α PX domain, p47phox PX domain and GST) 
 A single colony was selected from a LB ampicillin plate and inoculated into 5 ml of LB 
broth containing 10 µl of 500x ampicillin (50 mg/ml).  Then the mixture was incubated in a 
shaking incubator overnight at 37 oC. After incubation, the 5 ml culture was then transferred into 
a flask containing 1 liter LB broth with ampicillin and the initial optical density (O.D.) was 
measured using spectrophotometer. When O.D. 595 nm reached 0.5 – 0.6, Isopropyl β-D-1-
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thiogalactopyranoside (IPTG) was added to a final concentration of 0.1 mM into the culture to 
trigger the lac operon to induce protein expression. The culture was incubated in the shaking 
incubator overnight at 25 oC to prevent protein aggregation in the culture. After spinning down 
the cell pellets, 20 ml of lysis extraction buffer (20 mM Tris pH7.4, 1% Triton, mg/ml lysozyme, 
5 m DTT and 2 tablets of protease inhibitors, Roche #11-836-170-001) was added to the cell 
pellets and the mixture was incubated with rotation at 4 oC for 1 hours. Ultra-sonication was used 
to physically lyse the cells (the cell culture was kept in ice water bath to avoid protein 
denaturation). The sonicator probe was placed into the ice water for 3 times each for 30 seconds 
at 50% amplitude and then the probe was directly submerged into the cell culture for 30 seconds 
with 50% amplitude to lyse the cells.  
The homogenized lysate was subjected to centrifugation at 10,000 xG for 20 minutes at 4 
oC. The cell debris was removed (20 µl cell lysate was saved for positive control) and then 5 ml 
of glutathione sepharose 4B (GE #17-0756-01) was added into the lysate and incubated at 4 oC 
with rotation for 2 hours. Prior adding to the lysate, the glutathione sepharose 4B was prepared 
by three washing with 45 ml of PBS and spun at 500 xG for 5 minutes. The GST-tagged 
recombinant protein (bound to sepharose beads) was collected by using a chromatography 
column with 50 ml of 25 mM glutathione elution buffer (50 mM Tris HCL, 25 mM Glutathione 
at a final pH of 8.0). The protein was collected into seven separate elutions in 15 ml conical 
tubes each containing 5 ml of eluted protein. A small aliquot (20 µl) of each elution was run on 
an SDS-PAGE gel (10%) to detect the present of protein in the eluate after staining with 
Coomassie Blue stain. Based on the appearance of the protein band intensities, the appropriate 
elutions were pooled together for the concentration step using Amicon Ultra Centrifugal Filters 
(MWCO 10 kDa) according to the manufacturer’s instructions. A second SDS-PAGE gel (10%) 
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was used to determine the concentration of the concentered protein by (by Coomassie staining) 
comparing with a known concentration protein (bovine serum albumin, 2mg/ml).  
 
Western Blot Analysis Proteins (hTks5 α PX domain, p47phox PX domain and GST) 
2X Laemmli loading buffer was added into 20 µl of purified protein and 20 µl bacterial 
lysate was used as positive control. All the samples were boiled at 98 oC for 10 minutes before 
being separated on a 15% SDS-PAGE gel and the protein was then transferred from the gel onto 
a nitrocellulose membrane using semi-dry electroblotting apparatus at 0.17 A for 30 minutes 
with 1x transfer buffer (232 g of Tris, 116 g of glycine, 148 ml of 10% SDS to 1L ddI H2O. 20% 
methanol was added before used). After blocking with 5% skim milk in TBS/(0.1% TWEEN), 
the membrane was incubated with an anti-GST antibody (1:1000 in TBST and 0.5% BSA) for 1 
hour at room temperature followed by washing with TBS/T buffer for 3 times and each time for 
5 minutes. After washing, the membrane was incubated with goat-anti-rabbit Alexa-fluor 680 
(1:1000 in TBST and 0.5% BSA) for another 1 hour and washed another three times with TBS/T 
followed by imaging on the LI-COR imager.   
 
 
Results 
 
Expression & Purification of Recombinant Protein (hTks5 α PX domain) 
The presence of GST-tagged recombinant protein (hTks5 α PX domain) in a Coomassie 
staining SDS-PAGE gel was observed as shown in Figure 4. On the lysate lane, an intensive 
protein bands appears at 40 kDa. The molecular weight of GST-tagged hTks5 α PX domain is 
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about 40 kDa. The molecular weight of GST protein is about 25 kDa (see Figure 7) and the PX 
domain is about 15 kDa. Different intensities protein bands appeared on lane #1 to #7, but the 
most concentrated eluted protein was on lane #2. The presence of bands indicated the eluted 
protein was successfully collected through the chromatography column with glutathione elution 
buffer. 
Different volumes of the concentrated protein and bovine serum albumin (BSA) were 
separated on SDS PAGE gel and stained with Coomassie Blue stain (see Figure 5). The intensity 
and thickness of protein bands appeared on the gel corresponded to the different volume of 
protein being loaded in the gel. The most intensive band that appeared on the BSA lane was 
loaded with 20 µl BSA. The concentration of BSA was 2 mg/ml. Therefore, by comparing the 
appearance of the band that we loaded with 1 µl of recombinant protein, the concentration of the 
recombinant protein could be deduced to be relatively high, approximately 50 mg/ml. When 
necessary we also determined protein concentration by a BCA assay (Pierce Biotechnology). 
 
Western Blot Analysis Proteins (hTks5 α PX domain, p47phox PX domain and GST) 
Western blot analysis was used to identify the recombinant protein and GST protein. As 
shown in Figure 6 and 7, the GST-tagged hTks5 α PX domain, p47phox PX domain and GST were 
recognized by anti-GST antibody (goat-anti-rabbit Alexa-fluor 680 antibody was used as 
secondary antibody against anti-GST). Figure 6 shows two bands appeared on each lane. The 
molecular weight of the GST tag was about 25 kDa and the GST-tagged hTks5 α PX domain was 
about 40 kDa (see Figure 7). The intensity of protein band demonstrated that the recombinant 
protein had high immunoreactivity. Figure 7 also shows a protein band for GST- tagged hTks4 α 
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PX domain (the recombinant protein was previously prepared by a lab member) is about 40 kDa, 
similar to GST-tagged hTks5 α PX domain, and the protein also reacted with anti-GST. 
 
 
 
 
 
Figure 4. Expression analysis of GST-tagged hTks5 α PX 
domain by Coomassie staining SDS-PAGE (10%). The gel 
image shows the presence of recombinant protein in the 
eluate. Recombinant protein was collected into seven 
separated conical tubes, #1 to #7. An intensive band 
appears at 40 kDa on the lysate lane (positive control) 
indicated the expression of recombinant protein in BL 21 
competent cells. 
 
 
 
 
  
 
 
 
Figure 5. Concentration analysis of GST-tagged hTks5 α PX 
domain by Coomassie staining SDS-PAGE (10%). The 
concentration of bovine serum albumin (BSA) was 2 
mg/ml. Compared to the intensity and thickness of the 
BSA protein bands, the concentration of the recombinant 
protein was relatively high.  
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Figure 6. Western blot analysis of GST-tagged hTks5 α 
PX domain by 15% SDS-PAGE, anti-GST and goat-anti-
rabbit Alexa-fluor 680. Two dilutions were performed 
(1: 10 and 1:20). The intensity and the thickness of the 
protein bands depended on the volume of diluted 
recombinant proteins. 
 
 
 
 
 
Figure 7. Western blot analysis of GST-tagged hTks5 α 
PX domain, GST-tagged hTks4 α PX domain, GST-tagged 
p47phox PX domain and GST by 15% SDS-PAGE, anti-GST 
and goat-anti-rabbit Alexa-fluor 680. The molecular 
weight of GST-tagged hTks5 α PX domain and GST-
tagged hTks4 α PX domain are about 40 kDa, GST-
tagged p47phox PX domain is about 38 kDa and the GST 
tag is about 25 kDa. 
 
 
 
 
 
Discussion 
 
The use of antibody probes to detect a particular protein of interest has been adapted 
widely in medical and biology research labs because this technology provides a highly specific 
molecular recognition of the target protein. For this reason, the development of a highly specific 
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rabbit mAb, which acts as an antigen-specific- probe, to detect the locations of the Tks 5 α 
isoform in cancer cell samples may provide a clue on how cancer cells invade and metastasize. 
In the present study, the purified hTks5 α PX domain, was used as an immunogen for the 
generation of mAb in rabbits.  The results obtained from gel electrophoreses indicated that hTks5 
α PX domain was successfully expressed and purified. The result from western blot analysis also 
revealed the recombinant protein has a high immunoreactivity to the anti-GST antibody. More 
importantly, the results from western blots on whole cell extracts and immunofluorescence (on 
mouse and human cancer cells) are promising (experiments performed by other lab members). 
Studies have shown Tks5 is highly expressed and localized to invadopodia in invasive cancer 
cells and tumor tissue such as breast cancers and melanomas (Courtneidge et al., 2005). Clinical 
study discovered that metastatic progression in lung adenocarcinomas patients associated with a 
high level expression of Tks5 α isoform (long isoform) and low level expression of Tks5 short 
isoform (Li et al., 2013). Tks5 is a large scaffolding protein and only the α isoform contains an 
amino terminal PX domain and five SH3 domains which functions are bind to other key 
regulators, such as PI (3,4) P2 and ADAMs, to control the formation of invadopodia (Abram et 
al., 2003; Buschman et al., 2009; Courtneidge et al., 2005; Courtneidge, 2012; Oikawa et al, 
2008). Taken together, to visualize and detect the locations of Tks5 α isoform in cancer cell 
samples using antibody probe with high specificity will provide insights on how Tks5 α regulates 
the cell signaling pathways in invasive cancer cells. This may also shed light on the potential 
development of a new anti-metastatic strategy that could inhibit the interactions between Tks5 α 
isoform and other key regulatory molecules.  
 For the past two decades, researchers have endeavored to develop rabbit mAb in 
biological research because hypothetically rabbit mAb may have the combination of the best 
15 
 
characteristics of mouse mAbs and rabbit antisera (Rossi et al., 2005). Nevertheless, mice have 
been widely used as model in medical and research labs centered on a well-known discovery of 
genetic similarity between humans and mice is high. To develop mouse mAb as a probe to target 
the PX domain or SH3 domains on Tks5 α isoform merits further investigation, because it will be 
interesting to see the differences in targeting effects between rabbit mAb and mouse mAb in 
mice and human cancer cell samples using immunofluorescent and immunohistochemistry 
analysis. Such research will also provide insight into how cancer progresses and metastasizes in 
mice as compared to humans.    
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